biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > another perspective on the recent Cresence transaction

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Jul 05, 2022 8:38pm

185 Views

Post# 34803791

RE:RE:another perspective on the recent Cresence transaction

,,the point that giving your science up to entities who have the baility to move it forward and maintain legal royalties if succes is realized is nothing new. I know of a couple of these biotechs which could have benefited from such a business model yeara goa and still got theor thumbs in their bums,,,,,bring it on Mie Mei and DrDR!!!!,,,woooooohoooooooo!!

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. Army